🚀 VC round data is live in beta, check it out!
SonoScape Valuation Multiples
Discover revenue and EBITDA valuation multiples for SonoScape and similar public comparables like Weigao Group, MicroPort, Vimian Group, Cofoe Medical and more.
SonoScape Overview
About SonoScape
Sonoscape Medical Corp is a Chinese manufacturer of medical devices for ultrasound diagnostic systems and transducers. The company's product categories include Ultrasound, Endoscope which also includes video equipment, and Electrocardiography consisting of veterinary ECG and resting ECG. Ultrasound category covers color Doppler trolley systems, color Doppler HCU, B/W trolley systems, and probe, among others. The organization has a business presence in China and in other countries.
Founded
2002
HQ
Employees
N/A
Website
Financials (LTM)
EV
$2B
SonoScape Financials
SonoScape reported last 12-month revenue of $351M and EBITDA of $35M.
In the same LTM period, SonoScape generated $218M in gross profit, $35M in EBITDA, and $35M in net income.
Revenue (LTM)
SonoScape P&L
In the most recent fiscal year, SonoScape reported revenue of $338M and EBITDA of $40M.
SonoScape expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $351M | XXX | $338M | XXX | XXX | XXX |
| Gross Profit | $218M | XXX | $210M | XXX | XXX | XXX |
| Gross Margin | 62% | XXX | 62% | XXX | XXX | XXX |
| EBITDA | $35M | XXX | $40M | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 12% | XXX | XXX | XXX |
| EBIT Margin | 9% | XXX | 8% | XXX | XXX | XXX |
| Net Profit | $35M | XXX | $29M | XXX | XXX | XXX |
| Net Margin | 10% | XXX | 9% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
SonoScape Stock Performance
SonoScape has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
SonoScape's stock price is $4.13.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | 0.0% | XXX | XXX | XXX | $0.07 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSonoScape Valuation Multiples
SonoScape trades at 4.5x EV/Revenue multiple, and 44.9x EV/EBITDA.
EV / Revenue (LTM)
SonoScape Financial Valuation Multiples
As of April 19, 2026, SonoScape has market cap of $2B and EV of $2B.
Equity research analysts estimate SonoScape's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
SonoScape has a P/E ratio of 50.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 4.5x | XXX | 4.7x | XXX | XXX | XXX |
| EV/EBITDA | 44.9x | XXX | 40.0x | XXX | XXX | XXX |
| EV/EBIT | 50.3x | XXX | 58.8x | XXX | XXX | XXX |
| EV/Gross Profit | 7.3x | XXX | 7.6x | XXX | XXX | XXX |
| P/E | 50.8x | XXX | 61.8x | XXX | XXX | XXX |
| EV/FCF | (548.7x) | XXX | (57.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified SonoScape Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
SonoScape Margins & Growth Rates
SonoScape's revenue in the last 12 month grew by 14%.
SonoScape's rule of 40 is 28% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
SonoScape's rule of X is 47% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
SonoScape Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 14% | XXX | 13% | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 12% | XXX | XXX | XXX |
| EBITDA Growth | 73% | XXX | 45% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 28% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 47% | XXX | XXX | XXX |
| S&M Expenses to Revenue | 28% | XXX | 29% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 6% | XXX | 6% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 21% | XXX | 21% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 54% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
SonoScape Public Comps
See public comps and valuation multiples for other Medical Devices and Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| SonoScape | XXX | XXX | XXX | XXX | XXX | XXX |
| Weigao Group | XXX | XXX | XXX | XXX | XXX | XXX |
| MicroPort | XXX | XXX | XXX | XXX | XXX | XXX |
| Vimian Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Cofoe Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Artivion | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
SonoScape M&A Activity
SonoScape acquired XXX companies to date.
Last acquisition by SonoScape was on XXXXXXXX, XXXXX. SonoScape acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by SonoScape
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSonoScape Investment Activity
SonoScape invested in XXX companies to date.
SonoScape made its latest investment on XXXXXXXX, XXXXX. SonoScape invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by SonoScape
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout SonoScape
| When was SonoScape founded? | SonoScape was founded in 2002. |
| Where is SonoScape headquartered? | SonoScape is headquartered in China. |
| Is SonoScape publicly listed? | Yes, SonoScape is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of SonoScape? | SonoScape trades under 300633 ticker. |
| When did SonoScape go public? | SonoScape went public in 2017. |
| Who are competitors of SonoScape? | SonoScape main competitors are Weigao Group, MicroPort, Vimian Group, Cofoe Medical. |
| What is the current market cap of SonoScape? | SonoScape's current market cap is $2B. |
| What is the current revenue of SonoScape? | SonoScape's last 12 months revenue is $351M. |
| What is the current revenue growth of SonoScape? | SonoScape revenue growth (NTM/LTM) is 14%. |
| What is the current EV/Revenue multiple of SonoScape? | Current revenue multiple of SonoScape is 4.5x. |
| Is SonoScape profitable? | Yes, SonoScape is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of SonoScape? | SonoScape's last 12 months EBITDA is $35M. |
| What is SonoScape's EBITDA margin? | SonoScape's last 12 months EBITDA margin is 10%. |
| What is the current EV/EBITDA multiple of SonoScape? | Current EBITDA multiple of SonoScape is 44.9x. |
| What is the current FCF of SonoScape? | SonoScape's last 12 months FCF is ($3M). |
| What is SonoScape's FCF margin? | SonoScape's last 12 months FCF margin is (1%). |
| What is the current EV/FCF multiple of SonoScape? | Current FCF multiple of SonoScape is (548.7x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.